Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
Center for Radiological Research, Columbia University, New York, New York.
Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):202-211. doi: 10.1016/j.ijrobp.2020.01.031. Epub 2020 Feb 6.
Exposure to ionizing radiation increases risk of breast cancer. Although proton radiation is encountered in outer space and in medicine, we do not fully understand breast cancer risks from protons owing to limited in vivo data. The purpose of this study was to comparatively assess the effects of γ-rays and protons on mammary tumorigenesis in APC mice.
Female APC mice were exposed to 1 GeV protons (1.88 or 4.71 Gy) and Cs γ-rays (2 or 5 Gy). Mice were euthanized 100 to 110 days after irradiation, at which point mammary tumors were scored, tumor grades were assessed, and relative biological effectiveness was calculated. Molecular phenotypes were determined by assessing estrogen receptor α (ERα) and human epidermal growth factor receptor 2 (HER2) status. ERα downstream signaling was assessed by immunohistochemistry.
Exposure to proton radiation led to increased mammary tumor frequency at both proton radiation doses compared with γ-rays. The calculated relative biological effectiveness for proton radiation-induced mammary tumorigenesis was 3.11 for all tumors and >5 for malignant tumors relative to γ-rays. Tumor frequency per unit of radiation was higher at the lower dose, suggesting a saturation effect at the higher dose. Protons induced more adenocarcinomas relative to γ-rays, and proton-induced tumors show greater ERα and HER2 positivity and higher activation of the ERα downstream PI3K/Akt and cyclin D1 pathways relative to γ-rays.
Our data demonstrate that protons pose a higher risk of mammary tumorigenesis relative to γ-rays. We also show that proton radiation-induced tumors in APC mice are ERα- and HER2-positive, which is consistent with our previous data on radiation-induced estrogenic response in wild-type mice. Although this study establishes APC as a model with adequate signal-to-noise ratio for space radiation-induced mammary tumorigenesis, further studies will be required to address the uncertainties in space radiation-induced breast cancer risk estimation.
电离辐射会增加乳腺癌的风险。虽然质子辐射存在于外太空和医学领域,但由于体内数据有限,我们尚未完全了解质子辐射对乳腺癌的风险。本研究旨在比较评估 1 GeV 质子(1.88 或 4.71 Gy)和 Cs γ 射线(2 或 5 Gy)对 APC 小鼠乳腺肿瘤形成的影响。
雌性 APC 小鼠接受 1 GeV 质子(1.88 或 4.71 Gy)和 Cs γ 射线(2 或 5 Gy)照射。照射后 100 至 110 天处死小鼠,此时对乳腺肿瘤进行评分,评估肿瘤分级,并计算相对生物效应。通过评估雌激素受体 α(ERα)和人表皮生长因子受体 2(HER2)状态确定分子表型。通过免疫组化评估 ERα 下游信号。
与 γ 射线相比,两种质子辐射剂量均导致乳腺肿瘤发生率增加。质子辐射诱导的乳腺肿瘤发生的相对生物效应为 3.11,相对于 γ 射线,恶性肿瘤的相对生物效应大于 5。较低剂量的单位辐射肿瘤发生率更高,提示高剂量存在饱和效应。与 γ 射线相比,质子诱导更多的腺癌,并且质子诱导的肿瘤显示更高的 ERα 和 HER2 阳性率,以及更高的 ERα 下游 PI3K/Akt 和细胞周期蛋白 D1 途径的激活。
我们的数据表明,与 γ 射线相比,质子会导致更高的乳腺肿瘤形成风险。我们还表明,APC 小鼠中的质子辐射诱导的肿瘤为 ERα 和 HER2 阳性,这与我们之前关于野生型小鼠辐射诱导的雌激素反应的研究结果一致。尽管这项研究确立了 APC 作为具有足够信噪比的空间辐射诱导乳腺肿瘤形成模型,但需要进一步研究来解决空间辐射诱导乳腺癌风险评估中的不确定性。